For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Nabilone - Nausea and vomiting (chemotherapy induced)
PAD Profile : Nabilone - Nausea and vomiting (chemotherapy induced)
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Netupitant/palonosetron hydrochloride
- Cyclizine hydrochloride
- Dexamethasone
- Domperidone
- Metoclopramide hydrochloride
- Ondansetron hydrochloride
- Olanzapine
- Haloperidol
- Prochlorperazine maleate
- Aprepitant
- Fosaprepitant
- Levomepromazine hydrochloride
- Granisetron
- Palonosetron hydrochloride
- Netupitant/palonosetron hydrochloride
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
Nabilone is not on any local Trust formulary and has been awarded a non-formulary status for this indication.
The Surrey & North West Sussex Area Prescribing Committee (APC) recommends Nabilone for chemotherapy induced nausea & vomiting in adult patients and it will be considered RED on the traffic light system.
Providers (NHS and non-NHS) will be solely liable for clinical governance, prescribing responsibility and costs of all prescriptions of nabilone when it is used off-label i.e. outside of its marketing authorisation. Shared care will not be supported for an off-label use of nabilone.
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.